Ravi Gupta appointed as Hong Kong Jockey Club Chair in Global Health and Co-Director of the Global Health Institute, Hong Kong

We’re delighted to announce the appointment of Professor Ravi Gupta as the newly established Chair in Global Health at the University of Cambridge and co-director of the GHI in Hong Kong. A world-renowned scientist, Professor Gupta will be based at the Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID) and lead the institute as a strategic focal point for the Cambridge Biomedical Campus’ research into immunity and infection.

Established in March 2024, the GHI is an international partnership between CITIID/University of Cambridge, the University of Hong Kong (HKU), and the International Vaccine Institute (IVI) in Seoul. The Institute will benefit from IVI’s expertise in vaccine development, HKU’s leadership in pandemic virology and epidemiology, and CITIID’s strength in human immunology and virology.

Backed by generous support from the Hong Kong Jockey Club Charities Trust, the GHI represents a new model of collaborative health research that unites world-leading scientists and research teams to drive innovation, enhance vaccine accessibility, nurture the next generation of global health experts, and advance global preparedness for future pandemics.

I am incredibly honoured to be taking up this exciting new position as co-director of HKJC GHI and a new chair in global health here at Cambridge. My vision is to build a world leading global health base in Cambridge and to enable transformative advances in pandemic preparedness through GHI and its evolving network of partners.

Professor Ravi Gupta

Ravi Gupta has been Professor of Clinical Microbiology at CITIID and the lead of the NIHR BRC Infection Theme. He was a co-chair of the Bulletin of the Atomic Scientists’ Independent Task Force on Research with Pandemic Risks, a fellow of the UK Academy of Medical Sciences, and was named one of Time Magazine’s 100 most influential people of 2020. Professor Gupta’s work spans molecular virology and the study of immunity to viruses such as HIV and SARS-CoV-2. He has advised the UK government on COVID-19 through SAGE and NERVTAG, and his work in HIV drug resistance led to change in WHO treatment guidelines for HIV.